Corticosteroids Topic of National HBPA Panel
by Blood-Horse Staff
Date Posted: 7/8/2005 7:55:33 AM
Last Updated: 7/8/2005 6:07:00 PM

Corticosteroids, which serve as anti-inflammatory agents, will be the focus of a panel discussion July 21 during the National Horsemen's Benevolent and Protective Association summer convention in Toronto, Canada.

National HBPA Medication Committee chairman Kent Stirling, the executive director of the Florida HBPA, will serve as moderator. The Florida affiliate recently rejoined the National HBPA after having defected last fall.

The panel discussion, titled "Corticosteroids in the racehorse: Where are we now, where are we going, and where should we be going?" will begin at 1 p.m. at the Westin Harbour Castle Hotel. The summer convention runs from July 20-24, with the National HBPA board of directors meeting scheduled for the final day.

Panelists include Dr. Cindy Kollias-Baker, a noted researcher and lab director of the University of Florida Racing Laboratory; Dr. Mary Scollay-Ward, track veterinarian at Calder Race Course and Gulfstream Park; Dr. Thomas Tobin, a noted Kentucky researcher and lab director; Dr. Tracy Turner, an equine surgeon and practicing veterinarian from Minnesota; Dr. Scot Waterman, executive director of the Racing Medication and Testing Consortium; and Dr. Mike Weber, manager of veterinary services for the Canadian Pari-Mutuel Agency.

Copyright © 2014 The Blood-Horse, Inc. All Rights Reserved.

SUBSCRIBE to The Blood-Horse magazine TODAY!